Fundraising Fox

Travere Therapeutics

NASDAQ: TVTX

1 known investors

travere.com ↗

Travere Therapeutics is a patient-centered biopharmaceutical company that develops therapies for people living with rare kidney disease. It also supports patients, caregivers, and advocates through education and community partnerships.

BiotechHealthtech

Investors · 1

Ligand PharmaceuticalsJupiter · $10M – $50M

Frequently asked questions

What does Travere Therapeutics do?
Travere Therapeutics is a patient-centered biopharmaceutical company that develops therapies for people living with rare kidney disease. It also supports patients, caregivers, and advocates through education and community partnerships.
Who are Travere Therapeutics's investors?
Travere Therapeutics's investors include Ligand Pharmaceuticals.